OTCMKTS:PVOTF BetterLife Pharma (PVOTF) Stock Price, News & Analysis → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free PVOTF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.13▼$0.1352-Week Range N/AVolume198,200 shsAverage Volume52,703 shsMarket Capitalization$21.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get BetterLife Pharma alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About BetterLife Pharma Stock (OTCMKTS:PVOTF)BetterLife Pharma, Inc. is an early stage pharmaceutical company, which engages in the development and commercialization of therapeutic pharmaceutical and nutraceutical products. It also offers drug delivery platform technologies. Its product lines include capsules, tablets, and softgels; bulk powder; stick packs; beverages; oral solutions; lotions, creams, and gels; pet food additives; gum, mints, and candies; and sexual health products. It distributes its product under the Pivot Naturals brand. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.Read More Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). PVOTF Stock News HeadlinesApril 17, 2024 | msn.comJardiance and Ofev propel Boehringer’s human pharma salesApril 15, 2024 | abcnews.go.comVertex Pharma scientist talks about the long road to developing non-addictive painkillersApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 11, 2024 | tmcnet.comBetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 4, 2024 | msn.comVictory Over Big Pharma Will Take More Than the IRAMarch 4, 2024 | finanznachrichten.deBetterLife Pharma Inc.: BetterLife's 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton UniversityFebruary 5, 2024 | theguardian.comThe tragedy of Leonard Farruku, the gifted young musician whose dream of a better life ended on the Bibby StockholmFebruary 1, 2024 | msn.comWeight loss drugs could create the first $1 trillion pharma companiesApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.January 2, 2024 | finance.yahoo.comBetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001November 16, 2023 | msn.comBig Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity ratesNovember 15, 2023 | tmcnet.comUS Patent and Trademark Office Publishes BetterLife's Comprehensive Patent for BETR-001 and Other LSD DerivativesNovember 13, 2023 | businesswire.comMedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI Program (Codename: mdc-TJK or TEV-‘749)October 25, 2023 | finance.yahoo.comLi3 Lithium Announces Appointment of Robert Metcalfe to the Board of DirectorsJune 28, 2023 | msn.comBetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD DerivativesMarch 12, 2023 | finance.yahoo.comEsperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQJanuary 26, 2023 | benzinga.comBetterLife Engages Canadian Healthcare Investment Firm, Aims For Clinical Trial ProgramsJanuary 22, 2023 | ca.finance.yahoo.comBetterLife Pharma Inc. (BETR.CN)June 21, 2022 | finance.yahoo.comBetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) ForumSee More Headlines Receive PVOTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:PVOTF Previous SymbolOTCMKTS:PVOTF CUSIPN/A CIK1464165 Webpivotpharma.com Phone(604) 805-7783FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,780,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-205.15% Return on Assets-147.23% Debt Debt-to-Equity RatioN/A Current Ratio3.62 Quick Ratio3.62 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares171,414,000Free FloatN/AMarket Cap$21.70 million OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesAhmad DoroudianChief Executive Officer & DirectorChris LuckyChief Operating OfficerMoira OngChief Financial OfficerKey CompetitorsMEI PharmaNASDAQ:MEIPSynlogicNASDAQ:SYBXGreen Organic DutchmanOTCMKTS:TGODFGlucoTrackNASDAQ:GCTKTherapeuticsMDNASDAQ:TXMDView All Competitors PVOTF Stock Analysis - Frequently Asked Questions How do I buy shares of BetterLife Pharma? Shares of PVOTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PVOTF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
